Hu Hai Bo
Hu Hai Bo — Chief Physician — Structural Heart Disease Center — Fuwai Hospital
Specialties
Minimally invasive interventional procedures for various congenital heart defects and valvular diseases in adults and children that do not require surgery, including: transcatheter patent foramen ovale closure, ventricular septal defect closure, atrial septal defect closure, patent ductus arteriosus closure, pulmonary valve balloon dilation, pulmonary arteriovenous fistula closure, aortic coarctation stenting, percutaneous mitral stenosis balloon dilation, post-myocardial infarction ventricular septal perforation closure, minimally invasive transcatheter aortic valve replacement (TAVR), left atrial appendage closure for atrial fibrillation, interventional closure of paravalvular leaks after surgical valve replacement, interventional closure of residual leaks after various cardiac surgeries, minimally invasive interventional treatment for mitral and tricuspid regurgitation without surgery, other interventional and hybrid treatments for congenital heart defects and valvular diseases, interventional and drug treatment for congenital heart defects combined with pulmonary hypertension, and other cardiovascular interventional treatments. Especially skilled in the diagnosis and interventional treatment of complex and difficult patent foramen ovale cases.
Education
Graduated from the Clinical Medicine Department of Tongji Medical University, and pursued a Doctor of Clinical Medicine degree at Peking Union Medical College without examination.
Professional Experience
Chief Physician, Professor, Master's Supervisor, Doctor of Medicine, Leader of the Interventional Radiology Medical Team at Fuwai Hospital, National Center for Cardiovascular Diseases, and concurrently Party Branch Secretary of the Structural Heart Disease Center at Fuwai Hospital. After obtaining a doctorate, he has mainly engaged in interventional treatment of cardiovascular diseases and imaging diagnostics, with nearly 20 years of experience in diagnosing and minimally invasive interventional treatment of congenital heart disease and valvular disease. He is skilled in various minimally invasive interventional procedures for congenital heart disease and valvular disease without open surgery, including: transcatheter ventricular septal defect closure, atrial septal defect closure, patent ductus arteriosus closure, pulmonary valve balloon dilation, patent foramen ovale closure, pulmonary arteriovenous fistula closure, coarctation of the aorta stenting, percutaneous mitral valve balloon dilation, minimally invasive transcatheter aortic valve replacement (TAVR), left atrial appendage closure for atrial fibrillation, interventional closure of paravalvular leakage after surgical valve replacement, interventional closure of various residual leaks after cardiac surgery, minimally invasive interventional techniques for mitral regurgitation, other interventional and hybrid treatments for congenital and valvular heart disease, interventional and drug treatment for congenital heart disease complicated with pulmonary hypertension, as well as other cardiovascular interventional treatments. He is particularly skilled in the diagnosis and interventional treatment of complex and difficult cases of patent foramen ovale-related diseases. He is also proficient in imaging diagnostics for various cardiovascular diseases, including CT, MRI, and angiography. As a member of the Fuwai expert team, he has been dispatched multiple times to domestic and foreign collaborative hospitals to independently conduct consultations and surgeries, accumulating over 5,000 various interventional procedures.
Professional Roles
National Health and Family Planning Commission Cardiovascular Intervention Technology Training Guidance Mentor, Secretary General of the Interventional Group of the Chinese Medical Promotion Association